Loading...
•
Dec 31, 2025
UHS Q4 2025 Earnings Report
UHS reported strong fourth quarter 2025 results with 9.1% revenue growth and a significant increase in net income driven by improved operating performance.
Key Takeaways
UHS generated net revenues of 4486048000 and net income attributable to UHS of 445941000 in Q4 2025. Operating income rose to 517232000 while both Acute Care and Behavioral Health segments delivered solid revenue growth.
Net revenues increased 9.1% year over year to 4486048000.
Net income attributable to UHS increased to 445941000 from 332397000.
Operating income rose to 517232000 from 472489000.
Both Acute Care and Behavioral Health segments reported revenue growth.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
For 2026, UHS forecasts net revenues between 18417000000 and 18789000000 and Adjusted EBITDA net of NCI between 2640552000 and 2789376000, with diluted EPS expected between 22.64 and 24.52.
Positive Outlook
- Midpoint revenue growth of 7.1% over 2025.
- Midpoint Adjusted EBITDA growth of 4.8% over 2025.
- Midpoint Adjusted EPS growth of 8.5% over 2025.
- Capital expenditures planned between 950000000 and 1100000000.
- Continued operational momentum across segments.
Challenges Ahead
- Forecast excludes nonrecurring and non-operational items.
- Exposure to Medicaid and Medicare reimbursement changes.
- Potential impact from Medicaid work requirements legislation.
- Interest rate sensitivity affecting borrowing costs.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...